C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations
New England Journal of Medicine Jul 17, 2019
Butler CC, et al. - Via a multicenter, open-label, randomized, controlled trial with patients who have chronic obstructive pulmonary disease (COPD), researchers examined the value of point-of-care testing of C-reactive protein (CRP) for lowering unnecessary antibiotic use without harming patients who have acute exacerbations of COPD. They randomized a total of 653 patients who consulted a clinician at 1 of 86 general medical practices in England and Wales for an acute exacerbation of COPD to either usual care guided by CRP point-of-care testing (CRP-guided group) or usual care alone (usual-care group). Observations revealed a lower percentage of patients who reported antibiotic use and who received antibiotic prescriptions from clinicians in primary care clinics in correlation to CRP-guided prescribing of antibiotics for exacerbations of COPD, with no evidence of harm.
Sign-up to continue reading. It is free & takes less than 2 mins
45 lakhs+ doctors trust M3 globally
Free & unlimited access to original articles and quizzes
Secure: we never sell your data
Sign up with M3 India to try daily quizzes and take part in competitionsTry M3 India / Log In
Why join our Market Research Panel?
- 10K+ Doctors participated in 40+ Indian and Global studies in 2018
- Average honorarium per study was Rs. 1,600 and total honoraria as high as Rs. 12,000 was earned by a Doctor